Activation of NF-κB by hepatitis B virus X protein through an IκB kinase-independent mechanism

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 280, Issue 4 43-4, 2001, Pages

  Purcell, Nicole H ^a,b   Yu, Chenfei ^a,b   He, Daoyao ^b   Xiang, Jialing ^a   Paran, Nir ^c   Didonato, Joseph A ^d   Yamaoka, Shoji ^e   Shaul, Yosef ^c   Lin, Anning ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b University of Alabama at Birmingham   (United States)

^c WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^d LERNER RESEARCH INSTITUTE   (United States)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

Inhibitor of nuclear factor B; Nuclear factor ; X protein of hepatitis B virus

Indexed keywords

CYTOKINE; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; PHORBOL ESTER; PROTEIN X; SERINE; TAX PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRUS PROTEIN; CHUK PROTEIN, HUMAN; CYSTEINE PROTEINASE; HEPATITIS B VIRUS X PROTEIN; IKBKB PROTEIN, HUMAN; IKBKE PROTEIN, HUMAN; MULTIENZYME COMPLEX; PROTEASOME; PROTEIN SERINE THREONINE KINASE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ARTICLE; EMBRYO; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; T CELL LYMPHOMA; VIRUS INFECTION; CELL LINE; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; FIBROBLAST; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSCRIPTION; GENETICS; HELA CELL; IMMUNOBLOTTING; LIVER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PLASMID;

CELL LINE; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE; HELA CELLS; HUMANS; I-KAPPA B KINASE; IMMUNOBLOTTING; LIVER; MULTIENZYME COMPLEXES; NF-KAPPA B; PHOSPHORYLATION; PLASMIDS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN-SERINE-THREONINE KINASES; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 0034996869     PISSN: 01931857     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpgi.2001.280.4.g669     Document Type: Article

References (74)

1. Baeuerle PA and Baltimore D. NF-κB: ten years after. Cell 87: 13-20, 1996.
2. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683, 1996.
3. Barnes PJ and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.
4. Beasley RP, Hwang LY, Lin CC, and Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 2: 1129-1133, 1981.
5. Bender K, Gottlicher M, Whiteside S, Rahmsdorf HJ, and Herrlich P. Sequential DNA damage-independent and -dependent activation of NF-κB by UV. EMBO J 17: 5170-5181, 1998.
6. Benn J and Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 91: 10350-10354, 1994.
7. Benn J, Su F, Doria M, and Schneider RJ. Hepatitis B virus HBx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. J Virol 70: 4978-4985, 1996.
8. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, and Ballard DW. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol 15: 2809-2818, 1995.
9. Brown K, Gerstberger S, Carlson L, Franzoso G, and Siebenlist U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267: 1485-1488, 1995.
10. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, and Miller RH. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67: 3085-3093, 1993.
11. Cheong J, Yi M, Lin Y, and Murakami S. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 14: 143-150, 1995.
12. Chirillo P, Falco M, Puri L, Artini M, Balsano C, and Levrero M. Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J Virol 70: 641-646, 1994.
13. Chu ZL, DiDonato JA, Hawiger J, and Ballard DW. The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ. J Biol Chem 273: 15891-15894, 1998.
14. Cohen L, Henzel WJ, and Baeuerle PA. IKAP is a scaffold protein of the IκB kinase complex. Nature 395: 292-296, 1998.
15. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, and Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388: 548-554, 1997.
16. DiDonato JA, Mercurio F, and Karin M. Phosphorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol Cell Biol 15: 1302-1311, 1995.
17. Doria M, Klein N, Lucito R, and Schneider RJ The hepatitis B virus HBx protein is a dual specificity cytoplasmic activator of Ras and nuclear activator of transcription factors. EMBO J 14: 4747-4757, 1995.
18. Fischer C, Page S, Weber M, Eisele T, Neumeier D, and Brand K. Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IκB kinase signalsome activation and IκB proteolysis. J Biol Chem 274: 24625-24632, 1999.
19. Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET Jr, Grant M, Connelly MA, Hambor JE, Marcu KB, and Greene WC. Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase alpha (IKKα) and IKKβ cellular kinases. Mol Cell Biol 18: 5157-5165, 1998.
20. Harhaj EW, and Sun SC. IKKγ serves as a docking subunit of the IκB kinase (IKK) and mediates interaction of IKK with the human T-cell leukemia virus Tax protein. J Biol Chem 274: 22911-22914, 1999.
21. Huang J, Kwong J, Sun EC, and Liang TJ. Proteosome complex as a potential target of hepatitis B virus X protein. J Virol 70:5582-9991, 1996.
22. Haviv I, Shamay M, Doitsh G, and Shaul Y. Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol 18: 1562-1569, 1998.
23. Haviv I, Vaizel D, and Shaul Y. The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol 15: 1079-1085, 1995.
24. Haviv I, Vaizel D, and Shaul Y. pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J 15:3413-3420, 1996.
25. Hawiger J, Veach RA, Liu XY, Timmons S, and Ballard DW. IκB kinase complex is an intracellular target for endotoxic lipopolysaccharide in human monocytic cells. Blood 94: 1711-1716, 1999.
26. Imbert V, Rupec RA, Livolsi A, Pahl HL, Traenckner EB, Mueller-Dieckmann C, Farahifar D, Rossi B, Auberger P, Baeuerle PA, and Peyron JF. Tyrosine phosphorylation of IκB-α activates NF-κB without proteolytic degradation of IκB-α. Cell 86: 787-798, 1996.
27. Jin DY, Giordano V, Kibler KV, Nakano H, and Jeang KT. Role of adapter function in oncoprotein-mediated activation of NF-κB human T-cell interacts directly with IκB kinase γ. J Biol Chem 274: 17402-17405, 1999.
28. Kekule AS, Lauer U, Weiss L, Luber B, and Hofschneider PH. Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361: 742-745, 1993.
29. Kim C-M, Koike K, Saito I, Miyamura T, and Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 353: 317-320, 1991.
30. Lallena MJ, Diaz-Meco MT, Bren G, Paya CV, and Moscat J. Activation of IκB kinase β by protein kinase C isoforms. Mol Cell Biol 19: 2180-2188, 1999.
31. Lara-Pezzi E, Armesilla AL, Majano PL, Redondo JM, and Lopez-Cabrera M. The hepatitis B virus X protein activates nuclear factor of activated T-cells (NF-AT) by cyclosporin A-sensitive pathway. EMBO J 17: 7066-7077, 1998.
32. Lee YH, and Yun YD. HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 273: 25510-25515, 1998.
33. Li N and Karin M. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms. Proc Natl Acad Sci USA 95: 13012-13017, 1998.
34. Li Q, Van Antwerp D, Mercurio F, Lee KF, and Verma IM. Severe liver degeneration in mice lacking the IκB kinase 2 gene. Science 284: 321-325, 1999.
35. Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, and Karin M. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis. J Exp Med 189: 1839-1845, 1999.
36. Lin A, Minden A, Martinetto H, Claret FX, Lange-Carter C, Mercurio F, Johnson LJ, and Karin M. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2. Science 268: 286-290, 1995.
37. Lin X, Cunningham ET, Jr., Mu Y, Geleziunas R, and Greene WC. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-κB acting through the NF-κB-inducing kinase and IκB kinases. Immunity 10: 271-280, 1999.
38. Lin Y, Nomura T, Cheong J, Dorjsuren D, Iida K, and Murakami S. Hepatitis B virus X protein is a transcription modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem 272: 7132-7139, 1997.
39. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS, and Mayo MW. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB. Mol Cell Biol 20: 1626-1638, 2000.
40. Maguire HF, Hoeffler JP, and Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science 252: 842-844, 1991.
41. Mercurio F, Murray BW, Shevchenko A, Bennett BL, Young DB, Li JW, Pascual G, Motiwala A, Zhu H, Mann M, and Manning AM. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol Cell Biol 19: 1526-1538, 1999.
42. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barbosa M, Mann M, Manning A, and Rao AF. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278: 860-866, 1997.
43. Meyer M, Caselmann WH, Schluter V, Schreck R, Hofschneider PH, and Baeuerle PA. Hepatitis B virus transactivator MHBst: activation of NF-κB, selective inhibition by antioxidants and integral membrane localization. EMBO J 11: 2991-3001, 1992.
44. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, and Okumura K. Differential regulation of IκB kinase a and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 95: 3537-3542, 1998.
45. Nemoto S, DiDonato JA, and Lin A. Coordinate regulation of IκB kinases by mitogen-activated protein kinase kinase kinase 1 and NF-κB-inducing kinase. Mol Cell Biol 18: 7336-7343, 1998.
46. Ninomiya-Tsuji J, Kishimoto K, Hiyama H, Inoue J, Cao Z, and Matsumoto K. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256, 1999.
47. O'Connell MA, Bennett BL, Mercurio F, Manning AM, and Mackman N. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem 273: 30410-30414, 1998.
48. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM, and Donner DB. NF-κB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 401: 82-85, 1999.
49. Peters RT, Liao SM, and Maniatis T. IKK∈ is part of a novel PMA inducible IκB kinase complex. Mol Cell 5: 513-522, 2000.
50. Pomerantz JL and Baltimore D. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18: 6694-6704, 1999.
51. Qadri I, Maguire HF, and Siddiqui A. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein. Proc Natl Acad Sci USA 92: 1003-1007, 1995.
52. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, and Rothe M. Identification and characterization of an IκB kinase. Cell 90: 373-383, 1997.
53. Romashkova JA and Makarov SS. NF-κB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90, 1999.
54. Rothwarf DM, Zandi E, Natoli G, and Karin M. IKK-γ is an essential regulatory subunit of the IκB kinase complex. Nature 395: 297-300, 1998.
55. Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, and Akira S. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases. Int Immunol 11: 1357-1362, 1999.
56. Su F and Schneider RJ. Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 70: 4558-4566, 1997.
57. Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Hardy KL, and Goeddel DV. Embryonic lethality, liver degeneration, and impaired NF-κB activation in IKK-β-deficient mice. Immunity 10: 421-429, 1999.
58. Thanos D and Maniatis T. NF-κB: a lesson in family values. Cell 80: 529-532, 1995.
59. Traenckner EB, Wilk S, and Baeuerle PA. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J 13: 5433-5441, 1994.
60. Truant R, Antunovic J, Greenblatt J, Prives C, and Gromlish JA. Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation. J Virol 69: 1851-1859, 1995.
61. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, and Jay G. Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9: 41-47, 1995.
62. Uhlik M, Good L, Xiao G, Harhaj EW, Zandi E, Karin M, and Sun SC. NF-κB-inducing kinase and IκB kinase participate in human T-cell leukemia virus I Tax-mediated NF-κB activation. J Biol Chem 273: 21132-21136, 1998.
63. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, and Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev 9: 2723-2735, 1995.
64. Wang H-D, Trivedi A, and Johnson DL. Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein. Mol Cell Biol 18: 7086-7094, 1998.
65. Wei Y, Fourel G, Ponzetto A, Silvestro M, Tiollais P, and Buendia MA. Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J Virol 66: 5465-5276, 1992.
66. Weil R, Sirma H, Giannini C, Kremsdorf D, Bessia C, Dargemont C, Brechot C, and Israel A. Direct association and nuclear import of the hepatitis B virus X protein with the NF-κB inhibitor IκBα. Mol Cell Biol 19: 6345-6354, 1999.
67. Whiteside T, Ernst KM, Lebail O, Laurent-Winter C, Rice N, and Israel A. N- and C-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity. Mol Cell Biol 15: 5339-5345, 1995.
68. Woronicz JD, Gao X, Cao Z, Rothe M, and Goeddel DV. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK. Science 278: 866-869, 1997.
69. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay HE, and Israel A. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation. Cell 93: 1231-1240, 1998.
70. Yin M-J, Christerson LB, Yamamoto Y, Kwak Y-T, Xu S, Mercurio F, Barbosa M, Cobb MH, and Gaynor RB. HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell 93: 875-884, 1998.
71. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, and Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91: 243-252, 1997.
72. Zhao Q, and Lee FS. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-κB through IκB kinase-α and IαB kinase-β. J Biol Chem 274: 8355-8358, 1999.
73. Zheng C, Xiang J, Hunter T, and Lin A. The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity. J Biol Chem 274: 28966-28971, 1999.
74. Zoulim F, Saputelli J, and Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68: 2026-2030, 1994.